Phytochemicals Targeting VEGF and VEGF-Related Multifactors as Anticancer Therapy

Area of Science:

• Oncology
• Molecular Biology
• Pharmacology

Background:

• Vascular Endothelial Growth Factor (VEGF) signaling is crucial for cancer progression beyond angiogenesis.
• Multiple interacting factors, including neuropilins, tyrosine kinases, immunodeficiencies, and integrins, contribute to VEGF-mediated cancer initiation.
• Targeting these VEGF-interacting factors presents a strategy for inhibiting tumor progression.

Purpose of the Study:

• To elucidate the complex interactions between VEGF, cancer-promoting factors, and natural product-derived phytochemicals.
• To review the potential of phytochemicals in inhibiting cancer growth by targeting VEGF signaling pathways.
• To inform the development of multi-targeted strategies for cancer prevention and treatment.

Main Methods:

• Literature review and synthesis of existing research on VEGF signaling in cancer.
• Analysis of the mechanisms by which phytochemicals interact with VEGF and associated factors.
• Identification of key signaling pathways involved in VEGF-mediated cancer promotion.

Main Results:

• VEGF's role in cancer is multifaceted, involving interactions with neuropilins, tyrosine kinases, immunodeficiencies, and integrins.
• Phytochemicals from natural products demonstrate the ability to interfere with these VEGF-promoting factors.
• These interactions can lead to the inhibition of critical signaling pathways that drive cancer growth.

Conclusions:

• Understanding the interplay between VEGF and its associated factors is key to developing effective cancer therapies.
• Natural products and their phytochemicals represent a promising avenue for multi-targeted cancer prevention and treatment by modulating VEGF signaling.
• Further research into these interactions could lead to novel therapeutic strategies with reduced side effects.